This finding further revealed the underlying molecular mechanism of LHB-induced HCC development and identified potential targets for interfering with LHB-induced aneuploidy cycles, which may be helpful for patients with failed HBsAg serum clearance after antiviral treatment. Here, LHB is linked to hepatocellular carcinoma.